Doctor Nicolas del-Cuerpo-Salinas
UNIVERSITY HOSPITAL SAN JUAN DE ALICANTE, Sant Joan d'Alacant (Spain)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Cardiovascular prevention with GLP1 agonists in high or very-high cardiovascular risk irrespective of diabetes.
Event: ESC Congress 2024
Topic: Secondary Prevention
Session: Obesity and pre-diabetes: where do we stand today on prevention and treatment?
Heart failure and renal outcomes in patient treated with GLP1 agonists.
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Biomarkers to guide the treatment of heart failure: where are we going?
